Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 1,386.9% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 55,224 shares of the semiconductor company's stock after buying an additional 51,510 shares during the quarter. Synopsys comprises about 0.0% of Livforsakringsbolaget Skandia Omsesidigt's portfolio, making the stock its 29th largest holding. Livforsakringsbolaget Skandia Omsesidigt's holdings in Synopsys were worth $28,312,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently modified their holdings of the stock. Williams Jones Wealth Management LLC. boosted its stake in shares of Synopsys by 0.5% in the 4th quarter. Williams Jones Wealth Management LLC. now owns 4,650 shares of the semiconductor company's stock valued at $2,257,000 after purchasing an additional 22 shares during the last quarter. Hardy Reed LLC boosted its stake in shares of Synopsys by 0.7% in the 1st quarter. Hardy Reed LLC now owns 3,290 shares of the semiconductor company's stock valued at $1,411,000 after purchasing an additional 22 shares during the last quarter. Resurgent Financial Advisors LLC boosted its stake in shares of Synopsys by 2.7% in the 1st quarter. Resurgent Financial Advisors LLC now owns 832 shares of the semiconductor company's stock valued at $357,000 after purchasing an additional 22 shares during the last quarter. Trust Asset Management LLC boosted its stake in shares of Synopsys by 1.3% in the 1st quarter. Trust Asset Management LLC now owns 1,766 shares of the semiconductor company's stock valued at $757,000 after purchasing an additional 22 shares during the last quarter. Finally, Harbour Investments Inc. boosted its stake in shares of Synopsys by 10.8% in the 1st quarter. Harbour Investments Inc. now owns 235 shares of the semiconductor company's stock valued at $101,000 after purchasing an additional 23 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.
Analyst Ratings Changes
A number of research firms recently issued reports on SNPS. Robert W. Baird reiterated a "neutral" rating and set a $535.00 target price (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. KeyCorp dropped their target price on shares of Synopsys from $660.00 to $590.00 and set an "overweight" rating on the stock in a research report on Wednesday, September 10th. Mizuho dropped their target price on shares of Synopsys from $700.00 to $600.00 and set an "outperform" rating on the stock in a research report on Thursday, September 11th. Baird R W downgraded shares of Synopsys from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, September 10th. Finally, Morgan Stanley dropped their target price on shares of Synopsys from $715.00 to $510.00 and set an "overweight" rating on the stock in a research report on Thursday, September 11th. Eleven investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $585.33.
Get Our Latest Stock Report on Synopsys
Synopsys Stock Performance
SNPS opened at $419.20 on Tuesday. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52. The company's fifty day moving average price is $588.04 and its two-hundred day moving average price is $506.89. Synopsys, Inc. has a 1-year low of $365.74 and a 1-year high of $651.73. The company has a market cap of $77.87 billion, a price-to-earnings ratio of 32.90, a PEG ratio of 5.60 and a beta of 1.14.
Insider Buying and Selling at Synopsys
In other news, Director Robert G. Painter bought 350 shares of the stock in a transaction dated Thursday, September 11th. The stock was bought at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the acquisition, the director directly owned 2,291 shares in the company, valued at approximately $974,683.04. This trade represents a 18.03% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the completion of the sale, the executive owned 1,485 shares of the company's stock, valued at approximately $699,746.85. This represents a 85.85% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 24,031 shares of company stock worth $13,168,999. Corporate insiders own 0.62% of the company's stock.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.